Centre Medico Chirurgical Ambroise Pare Hartmann — Clinical Trial Site

58 Registered trials

27 Currently recruiting

Organisation

Centre Medico Chirurgical Ambroise Pare Hartmann

Location

Neuilly-Sur-Seine, France

Identifier

ORG-100046315

Address

48 Ter Boulevard Victor Hugo, 92200, France

Departments

/
#6002: Intensive Care Unit
Cardiology
Cardiology Department
Centre satellite
Chirurgie cardiaque et interventionnelle
CLINIQUES AMBROISE PARE
FR10003: Institut des MICI
FR10008: Institut des MICI
Gastro-entérologie
GASTRO-ENTEROLOGIE ET HEPATOLOGIE
GASTROENTEROLOGIE
gastroenterology
Hépato-Gastro-Entérologie
Hepato-gastro-enterology
Institut des MICI
Intensive care
Intensive care medicine
lnstitut des MICI
maladies inflammatoires chroniques de l’intestin
Medical Oncology
Oncologie medicale
Oncology
Radiation Oncology
Réanimation
Service d’oncologie

Clinical trials at this site (58)

Search interface

PASSPORT Ended

2023-508584-72-00 Immune Bowel Disease (including Crohn's disease and Ulc 5 2024-07-10
Efficacy and Safety of JNJ-77242113 in Participants with Moderately to Severely Active Ulcerative Colitis Ended

2023-504673-20-00 Ulcerative Colitis 4 2023-12-06
Detection of tumor DNA in the blood of patients receiving standard therapy for hormone receptorpositive (HR+) non-HER2 expressing (HER2-) me… Ended

2022-502372-22-01 Metastatic Breast Cancer HR+, HER2- 4 2023-10-19
A single-arm, open-label study to evaluate the efficacy and safety of ABBV-668 in subjectswith moderate to severe ulcerative colitis Ended

2022-501263-41-00 Ulcerative Colitis 4 2023-08-10
ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Ended

2022-500536-11-01 Moderately to severely active ulcerative colitis 5 2023-06-08
A multi-center study to evaluate the safety, tolerability and efficacy of TIN816 in patients at risk for acute kidney injury following a car… Ended

2024-511621-64-00 Acute kidney injury 4 2023-01-18
SENS-401 to Prevent the Ototoxicity induced by Cisplatin in Adult Subjects with a Neoplastic Disease Ended

2024-511713-38-00 Cisplatine induced hearing loss 4 2022-12-30
The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic… Ended

2024-517251-12-00 Recurrent or metastatic head and neck squamous cell car 5 2021-11-02
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn's Disease Ended

2024-511553-22-00 Moderately to Severely Active Crohn's Disease 5 2018-10-05
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn's Disease Ended

2023-510426-33-00 Moderately to Severely Active Crohn's Disease 5 2018-09-27